HIKMA Pharmaceuticals PLC

AGM Information • Apr 24, 2025

Co. No.5557934

HIKMA PHARMACEUTICALS PLC (the "Company")

RESOLUTIONS PASSED AT THE ANNUAL GENERAL MEETING ON 24 APRIL 2025

At the Annual General Meeting of the Company duly convened and held at Sofitel London St. James, 6 Waterloo Place, London SW1Y 4AN on 24 April 2025 at 11:30 am, the following resolutions were duly passed:

Resolution 16 (Ordinary Resolution)

That the Board be generally and unconditionally authorised for the purposes of section 551 of the Act, to exercise all the powers of the Company to allot shares in the capital of the Company and to grant rights to subscribe for, or convert any security into, shares in the Company:

• a. up to an aggregate nominal amount of £7,396,215 (such amount to be reduced by any allotments or grants made under paragraph b. below in excess of such sum); and
• b. comprising equity securities (as defined in section 560 of the Act) up to an aggregate nominal amount of £14,792,430 (such amount to be reduced by any allotments or grants made under paragraph a. above) in connection with or pursuant to a pre-emptive offer (including an offer by way of a rights issue or open offer):
  • i. in favour of holders of Ordinary Shares in proportion (as nearly as practicable) to their existing holdings; and
  • ii. to holders of other equity securities, as required by the rights of those securities or as the Board otherwise consider it necessary,

but subject to such limits, restrictions or other arrangements as the Board may consider necessary or appropriate to deal with fractional entitlements, treasury shares, record dates and/or legal, regulatory or practical difficulties which may arise under the laws of, or the requirements of any regulatory body or stock exchange in, any territory or any other matter whatsoever, such authority to apply until the conclusion of the next AGM (or, if earlier, until the close of business on 24 July 2026), save that, in each case, the Company may during this period make any offer or enter into any agreements which would or might require shares to be allotted, or rights to subscribe for or convert securities into shares to be granted, after the authority ends and the Board may allot shares, or grant rights to subscribe for or convert any security into shares, in pursuance of any such offer or agreement as if the authority conferred hereby had not ended.

Resolution 17 (Special Resolution)

That if Resolution 16 is passed, the Board be given power to allot equity securities (as defined in section 560 of the Act) of the Company for cash under the authority conferred by that resolution, and/or sell Ordinary Shares held by the Company as treasury shares for cash, as if section 561 of the Act did not apply to any such allotment or sale, such power to be limited:

• a. to the allotment of equity securities and sale of treasury shares in connection with an offer of, or invitation to apply for, equity securities (but in the case of the authority granted under paragraph b. of Resolution 16, by way of a pre-emptive offer (including a rights issue or open offer)):
  • i. to Ordinary Shareholders in proportion (as nearly as may be practicable) to their existing holdings; and
  • ii. to holders of other equity securities, as required by the rights of those securities, or as the Board otherwise considers necessary,

and so that the Board may impose any limits or restrictions and make any arrangements which it considers necessary or appropriate to deal with treasury shares, fractional entitlements, record dates, legal, regulatory and/or practical problems in, or under the laws of, any territory or any other matter;

• b. in the case of the authority granted under paragraph a. of Resolution 16 and/or in the case of any sale of treasury shares, to the allotment of equity securities or sale of treasury shares (otherwise than under paragraph a. above) up to a nominal amount of £2,218,865; and
• c. to the allotment of equity securities or sale of treasury shares (otherwise than under paragraph a. or paragraph b. above) up to a nominal amount equal to 20% of any allotment of equity securities or sale of treasury shares from time to time under paragraph b. above, such power to be used only for the purposes of making a follow-on offer which the Board determines to be of a kind contemplated by paragraph 3 of Section 2B of the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the Pre-Emption Group prior to the date of this Notice,

such power to apply until the end of next year's AGM (or, if earlier, until the close of business on 24 July 2026) but, in each case, during this period the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the power ends and the Board may allot equity securities (and sell treasury shares) under any such offer or agreement as if the power had not ended.

Resolution 18 (Special Resolution)

That if Resolution 16 is passed, the Board be given the power, in addition to any power granted under Resolution 17, to allot equity securities (as defined in the Act) for cash under the authority granted under paragraph a. of Resolution 16 and/or to sell Ordinary Shares held by the Company as treasury shares for cash as if section 561 of the Act did not apply to any such allotment or sale, such power to be:

• a. limited to the allotment of equity securities or sale of treasury shares up to a nominal amount of £2,218,865, such power to be used only for the purposes of financing a transaction which the Board determines to be either an acquisition or a specified capital investment of a kind contemplated by the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the Pre-Emption Group prior to the date of this Notice or for the purposes of refinancing such a transaction within 12 months of its taking place; and
• b. b. limited to the allotment of equity securities or sale of treasury shares (otherwise than under paragraph a. above) up to a nominal amount equal to 20% of any allotment of equity securities or sale of treasury shares from time to time under paragraph a. above, such power to be used only for the purposes of making a follow-on offer which the Board determines to be of a kind contemplated by paragraph 3 of Section 2B of the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the Pre-Emption Group prior to the date of this Notice,

such power to apply until the end of next year's AGM (or, if earlier, until the close of business on 24 July 2026) but, in each case, during this period the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the power ends and the Board may allot equity securities (and sell treasury shares) under any such offer or agreement as if the power had not ended.

Resolution 19 (Special Resolution)

That the Company is generally and unconditionally authorised for the purposes of section 701 of the Act to make one or more market purchases (within the meaning of section 693(4) of the Act) of any of its Ordinary Shares on such terms and in such manner as the Board may from time to time determine, provided that:

a. the maximum aggregate number of Ordinary Shares which may be purchased is 22,188,645;

• b. the minimum price which may be paid for each Ordinary Share is 10 pence which amount shall be exclusive of expenses, if any;
• c. the maximum price (exclusive of expenses) which may be paid for an Ordinary Share is the highest of:
  • iii. an amount equal to 5% above the average market value of an Ordinary Share for the five business days immediately preceding the day on which that Ordinary Share is contracted to be purchased; and
  • iv. the higher of the price of the last independent trade and the highest current independent purchase bid for an Ordinary Share on the trading venue where the purchase is carried out, including when the shares are traded on different trading venues;
• d. unless previously renewed, revoked or varied, this authority shall expire at the conclusion of the AGM to be held in 2026 (or, if earlier, 24 July 2026); and
• e. under this authority the Company may enter into a contract to purchase Ordinary Shares which would or might be executed wholly or partly after the expiry of this authority, and the Company may make purchases of Ordinary Shares pursuant to any such contract as if this authority had not expired.

Resolution 20 (Special Resolution)

That a general meeting of Shareholders of the Company other than an AGM may be called on not less than 14 clear days' notice.

Resolution 21 (Ordinary Resolution on which only Independent Shareholders were entitled to vote)

That approval is granted for the waiver by the Takeover Panel of any obligation that could arise, pursuant to Rule 9 of the Takeover Code, for the Concert Party, collectively or individually, to make a general offer for all the issued Ordinary Share capital of the Company, following any increase in the percentage of Ordinary Shares of the Company carrying voting rights in which the Concert Party is interested resulting from the exercise by the Company of the authority to purchase its own Ordinary Shares granted to the Company pursuant to Resolution 19 above, provided that such approval shall expire at the conclusion of the next AGM of the Company or on 24 July 2026, whichever is earlier.

Resolution 22 (Ordinary Resolution on which only Independent Shareholders were entitled to vote)

That approval is granted for the waiver by the Takeover Panel of any obligation that could arise, pursuant to Rule 9 of the Takeover Code, for the Concert Party, collectively or individually, to make a general offer for all the issued Ordinary Share capital of the Company, following any increase in the percentage of Ordinary Shares of the Company carrying voting rights in which the Concert Party is interested resulting from the grant, vesting, transfer and/or issue of up to 430,000 Ordinary Shares to members of the Concert Party pursuant to the 2026 Awards Grant.

Helen Middlemist Group Company Secretary